Parental knowledge and behaviour to prevent environmental P. aeruginosa acquisition in their children with CF

Journal of Cystic Fibrosis

Volumn 7, Issue 3, 2008, Pages 231-237

  Ullrich, Gerald ^a   Wiedau, Susanne ^b   Schulz, Wolfgang ^b   Steinkamp, Gratiana ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^c Clinical Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL TRANSMISSION; BATH; CAREGIVER; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; ENVIRONMENTAL SANITATION; FEMALE; HEALTH BELIEF; HEALTH EDUCATION; HUMAN; INFECTION PREVENTION; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; PARENTAL ATTITUDE; POSTAL MAIL; PSEUDOMONAS AERUGINOSA; QUESTIONNAIRE;

CHILD; CHILD, PRESCHOOL; COMORBIDITY; CYSTIC FIBROSIS; ENVIRONMENT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYGIENE; MALE; PSEUDOMONAS INFECTIONS; QUESTIONNAIRES;

EID: 43249121866     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2007.09.003     Document Type: Article

References (30)

1. Kraemer R., Delosea N., Ballinari P., Gallati S., and Crameri R. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. Am J Respir Crit Care Med 174 (2006) 1211-1220
2. Nixon G.M., Armstrong D.S., Carzino R., Carlin J.B., Olinsky A., Robertson C.F., et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 138 (2001) 699-704
3. Vonberg R.P., and Gastmeier P. Isolation of infectious cystic fibrosis patients: results of a systematic review. Infect Control Hosp Epidemiol 26 (2005) 401-409
4. Renders N.H., Sijmons M.A., van Belkum A., Overbeek S.E., Mouton J.W., and Verbrugh H.A. Exchange of Pseudomonas aeruginosa strains among cystic fibrosis siblings. Res Microbiol 148 (1997) 447-454
5. Bauernfeind A., and Przyklenk B. Pseudomonas aeruginosa. In: Reinhardt D., Götz M., and Kraemer R. (Eds). Cystische Fibrose (2001), Springer, Berlin 83-90
6. Stern M., Sens B., Wiedemann B., Busse O., Damm G., and Wenzlaff P. Qualitätssicherung Mukoviszidose 2003. Überblick über den Gesundheitszustand der Patienten in Deutschland [Quality assurance in cystic fibrosis 2003. An overview on the health status of patients in Germany] (2004), Zentrum für Qualitätsmanagement im Gesundheitswesen (Einrichtung der Ärztekammer Niedersachsen)
7. McManus T.E., Beattie D., Graham C., Moore J.E., and Elborn J.S. Cystic fibrosis genotype and bacterial infection: a possible connection. Br J Biomed Sci 62 (2005) 85-88
8. Plant B.J., Gallagher C.G., Bucala R., Baugh J.A., Chappell S., Morgan L., et al. Cystic fibrosis, disease severity, and a macrophage migration inhibitory factor polymorphism. Am J Respir Crit Care Med 172 (2005) 1412-1415
9. Rose V.D., Arduino C., Cappello N., Piana R., Salmin P., Bardessono M., et al. Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis. Eur J Hum Genet 13 (2004) 96-101
10. Pier G.B., Saunders J.M., Ames P., Edwards M.S., Auerbach H., Goldfarb J., et al. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis. N Engl J Med 317 (1987) 793-798
11. Barben J., Hafen G., and Schmid J. Pseudomonas aeruginosa in public swimming pools and bathroom water of patients with cystic fibrosis. J Cyst Fibros 4 (2005) 227-231
12. Saiman L., and Siegel J. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol 24 (2003) S6-S52
13. Saiman L., and Siegel J. Infection control in cystic fibrosis. Clin Microbiol Rev 17 (2004) 57-71
14. Döring G., and Mukoviszidose e.V. Lungeninfektionen bei Mukoviszidose: Therapie und Prävention Ein Leitfaden für Ärzte und Betroffene [Lung infection in cystic fibrosis: Treatment and prevention] (2002), Deutscher Ärzte-Verlag
15. Steinkamp G., and Ullrich G. Different opinions of physicians on the importance of measures to prevent acquisition of Pseudomonas aeruginosa from the environment. J Cyst Fibros 2 (2003) 199-205
16. Ullrich G., Wiedau-Goers, Steinkamp G., Bartig H.J., Schulz W., and Freihorst J. Parental fears of Pseudomonas infection and measures to prevent its acquisition. J Cyst Fibros 1 (2002) 122-130
17. Reinken L., and van Oost G. Longitudinale Körperentwicklung gesunder Kinder von 0 bis 18 Jahren [Longitudinal physical development of healthy children 0 to 18 years of age. Body length/height, body weight and growth velocity]. Klin Padiatr 204 (1992) 129-133
18. Quanjer P.H., Stocks J., Polgar G., Wise M., Karlberg J., and Borsboom G. Compilation of reference values for lung function measurements in children. Eur Respir J 2 (1989) 184s-261s
19. Havermans T., and Peosmanns M. Pseudomona aeruginosa: what parents know or would like to know better [Abstract 429]. J Cyst Fibros 4 (2005) 115s
20. Lee T.W., Brownlee K.G., Denton M., Littlewood J.M., and Conway S.P. Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center. Pediatr Pulmonol 37 (2004) 104-110
21. Frederiksen B., Lanng S., Koch C., and Hoiby N. Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment. Pediatr Pulmonol 21 (1996) 153-158
22. Frederiksen B., Koch C., and Hoiby N. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995). Pediatr Pulmonol 28 (1999) 159-166
23. Festini F., Buzzetti R., Bassi C., Braggion C., Salvatore D., Taccetti G., et al. Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review. J Hosp Infect 64 (2006) 1-6
24. Jones A.M., Dodd M.E., Doherty C.J., Govan J.R., and Webb A.K. Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa. Thorax 57 (2002) 924-925
25. McCallum S.J., Corkill J., Gallagher M., Ledson M.J., Hart C.A., and Walshaw M.J. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa. Lancet 358 (2001) 558-560
26. Panagea S., Winstanley C., Walshaw M.J., Ledson M.J., and Hart C.A. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces. J Hosp Infect 59 (2005) 102-107
27. Griffiths A.L., Jamsen K., Carlin J.B., Grimwood K., Carzino R., Robinson P.J., et al. Effects of segregation on an epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic. Am J Respir Crit Care Med 171 (2005) 1020-1025
28. Griffiths A.L., Armstrong D., Carzino R., and Robinson P. Cystic fibrosis patients and families support cross-infection measures. Eur Respir J 24 (2004) 449-452
29. Ullrich G., Wiedau-Goers, Steinkamp G., Bartig H.J., Schulz W., and Freihorst J. Prophylaxe der Ansteckung mit Pseudomonas aeruginosa aus Umgebungsquellen: Interviews mit Eltern mukoviszidosekranker Kinder [Preventing environmental acquisition of Pseudomonas aeruginosa: results from interviews with parents of children with cystic fibrosis]. In: Ullrich G., and Steinkamp G. (Eds). Mukoviszidose und Pseudomonas aeruginosa: Infektionsangst und Massnahmen zur Infektionsvermeidung [Cystic fibrosis and Pseudomonas aeruginosa: fear of infection and precautions against it] (2002), VAS Verlag, Frankfurt a.M. 89-106
30. Ullrich G., Wiedau-Goers, Bartig H.J., Schulz W., Ballmann M., and Steinkamp G. Pseudomonas aeruginosa (PsA) acquisition and infection: 2. parental fears and concerns. J Cyst Fibros 3 (2004) 106s